Ming‐Sound Tsao

3 ta ish

University Health Network

1. Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)

   Anna V. Tinker, Susan Ellard, Stephen Welch +7

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.002971

2. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

   Klaus P. Hoeflich, Juan Luo, Elizabeth A. Rubie +3

   Maqola20002 iqtibos

   ABIABI:AkademIndex/2026.other.308775

3. The landscape of somatic copy-number alteration across human cancers

   Rameen Beroukhim, Craig H. Mermel, Dale Porter +59

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.839373